Abstract
To evaluate the efficacy of emodepside against immature stages (L4) of Ancylostoma sp. 18 healthy kittens less than six months of agewere orally infected with approximately 300 infective Ancylostoma sp. larvae each, over two successive days. On day 7 after the first infection, ten kittens were dermally treated with emodepside 1.98 % w/w plus praziquantel 7.94% w/w at a dose rate of 3.2 mg/kg emodepside and 12.9 mg/kg praziquantel. The kittens were necropsied at the end of the prepatent period (21 days), and the intestines examined for Ancylostoma sp. The efficacy was calculated by using the average Ancylostoma sp. counts against the average of the untreated controls. Untreated kittens had an average count of 254 worms. Treatment on day 7 after the first infestation was 99.65% effective against immature stages (L4) of Ancylostoma sp. In a second experiment to test the efficacy of emodepside against immature stages (L3) of Toxocara sp. 18 healthy kittens less than six months of age were orally infected with approximately 100 infective Toxocara sp. eggs. On day 7 post infection, ten kittens were dermally treated with emodepside 1.98% w/v + praziquantel 7.94% w/v at a dose rate of 3.2 mg/kg emodepside and 12.9 mg/kg praziquantel. The kittens were necropsied at the end of the prepatent period (42 days) and the intestines examined for Toxocara sp. Efficacy was calculated by using the average Toxocara sp. counts against the average of the untreated controls. Untreated kittens had an average count of 37 worms. Treatment on day 7 after infection was 100% effective against immature stages (L3) of Toxocara sp.
Similar content being viewed by others
References
Altreuther G, Borgsteede FHM, Buch J, Charles SD, Cruthers L, Epe C, Young DR, Krieger KJ (2005). Efficacy of a topically administered combination of emodepside and praziquantel against mature and immature Ancylostoma tubaeforme in domestic cats. Parasitol. Res 97:S51–S57.
Harder A, von Samson-Himmelstjerna G (2002). Cyclooctadepsipeptides – a new class of anthelmintically active compounds. Parasitol Res (88):S481–S488.
Harder A, Schmitt-Wrede HP, Krucken J, Marinovski P, Wunderlich F, Willson J, Amliwala K, Holden-Dye L, Walker R (2003). Cyclooctadepsipeptides – an anthelmintically active class of compounds exhibiting a novel mode of action. Int J Antimicrob Agents 22:318–331.
Harder A, Holden-Dye L, Walker R, Wunderlich F (2005). Mechanisms of action of emodepside. Parasitol Res 97:S1–S10.
Reinemeyer CR, Charles SD, Buch J, Settje T, Altreuther G, Cruthers L, McCall JW, Young DR, Epe C (2005). Evaluation of the Efficacy of Emodepside + Praziquantel Topical Solution against Ascarid Infections (Toxocara cati or Toxascaris leonina) in Cats. Parasitol. Res 97:S41–S50.
Overgaauw PA (1997). Aspects of Toxocara epidemiology: human toxocarosis. Crit Rev Microbiol 23:215-231.
Prociv P (1998). Zoonotic hookworm infections (ancylostomosis). In: Palmer SR, Soulsby EJL, Smipson DIH (eds) Zoonoses. Oxford University Press, Oxford, pp. 803–822.
Willson J, Amliwala K, Harder A, Holden-Dye L, Walker RJ (2003). The effect of the anthelmintic emodepside at the neuromuscular junction of the parasitic nematode Ascaris suum. Parasitology 126:79–86.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schaper, R., Altreuther, G. & Hopkins, T. Efficacy of Emodepside plus Praziquantel Topical Solution against Immature Stages of Nematodes (Ancylostoma sp. and Toxocara sp.) in Cats. Parasitol Res 101 (Suppl 1), 63–68 (2007). https://doi.org/10.1007/s00436-007-0612-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-007-0612-x